ShapeShapeauthorShapecrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShapeShape

Dechra introduces Sedadex to its anaesthesia and analgesia range

Dechra Veterinary Products has added the sedation and premedication product Sedadex to its portfolio of anaesthesia and analgesia therapies

13 November 2019, at 12:00pm

Sedadex, which has the active ingredient dexmedetomidine, is indicated for sedation and analgesia and for premedication prior to general anaesthesia in dogs and cats. It comes in a 10 ml vial and has a 56-day broached shelf life.

Claire Morgan, Brand Manager from Dechra said: “Sedadex is a highly selective α2 adrenoceptor agonist that is licensed for intravenous or intramuscular use in dogs and intramuscular injection in cats.

“It is a welcome addition to Dechra’s anaesthesia and analgesia range and compliments our existing therapies that include Comfortan, Sedator and Atipam